Regeneron (REGN) Enters $2.32B Collaboration With Parabilis to Target ‘Undruggable’ Proteins

26 5 月, 2026

One Min Read

1 Views

原文: https://finance.yahoo.com/sectors/healthcare/articles/regeneron-regn-enters-2-32b-195435032.html

Last Update: 26 5 月, 2026

Written By

Other Articles

Previous

T-Mobile (TMUS) Announces New Motorola Razr Lineup Featuring AI, 5G Advanced Capabilities

Next

Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept